A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
JAMA Surg. 2021 Feb 1;156(2):e205601. doi: 10.1001/jamasurg.2020.5601. Epub 2021 Feb 10.
JAMA Surg. 2021.
PMID: 33355651
Free PMC article.